Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients Undergoing Percutaneous Coronary Intervention Treated With the Glycoprotein IIb/IIIa Inhibitor Tirofiban

Military Medical Research - United Kingdom
doi 10.1186/s40779-016-0081-6
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Springer Science and Business Media LLC


Related search